Position in NVS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,303,909
+$18,518 QoQ
Shares Held
8,320
-1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#552
of 1,603 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 81%
Shared 8%
None 11%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHICAGO TRUST Co NA holds $42,770,408 across 10 Drug Manufacturers - General names. NVS ranks #7 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
55,260 | $13,905,626 | |
| 2 | LLY |
ELI LILLY & Co
|
7,888 | $9,461,103 | |
| 3 | JNJ |
Johnson & Johnson
|
21,762 | $5,526,895 | |
| 4 | MRK |
Merck & Co., Inc.
|
42,935 | $5,517,147 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
44,250 | $2,549,684 | |
| 6 | PFE |
Pfizer Inc
|
75,196 | $1,810,719 | |
| 7 | NVS |
Novartis AG
This page
|
8,320 | $1,303,909 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
9,103 | $1,150,072 |
All Filings in NVS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,303,909 | 8,320 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,285,391 | 8,415 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,132,463 | 8,214 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,100,298 | 8,580 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $952,469 | 7,871 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $556,730 | 4,994 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $417,167 | 4,287 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $495,045 | 4,304 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $419,771 | 3,943 | Shares | Sole | 2024-07-11 | |
| No filing history on record for this holder in this stock. | ||||||